Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

Colorcon
Dow
Mallinckrodt
Medtronic
Johnson and Johnson
Express Scripts

Last Updated: May 21, 2022

Investigational Drug Information for ISV-305


✉ Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug ISV-305?

ISV-305 is an investigational drug.

There have been 15 clinical trials for ISV-305. The most recent clinical trial was a Phase 3 trial, which was initiated on April 3rd 2020.

The most common disease conditions in clinical trials are Cataract, Inflammation, and Conjunctivitis, Bacterial. The leading clinical trial sponsors are InSite Vision, Sun Pharma Global FZE, and Bausch & Lomb Incorporated.

There are seven hundred and forty-four US patents protecting this investigational drug and thirty-six international patents.

Recent Clinical Trials for ISV-305
TitleSponsorPhase
Rib Fracture Analgesia Using CryoanalgesiaEpimed InternationalPhase 4
Rib Fracture Analgesia Using CryoanalgesiaUniversity of FloridaPhase 4
Rib Fracture Analgesia Using CryoanalgesiaUniversity of California, San DiegoPhase 4

See all ISV-305 clinical trials

Clinical Trial Summary for ISV-305

Top disease conditions for ISV-305
Top clinical trial sponsors for ISV-305

See all ISV-305 clinical trials

US Patents for ISV-305

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
ISV-305 See Plans and Pricing Phosphonate compounds for treatment of medical disorders Achillion Pharmaceuticals, Inc. (New Haven, CT) See Plans and Pricing
ISV-305 See Plans and Pricing Monomethylvaline compounds having phenylalanine side-chain modification at the C-terminus Seattle Genetics, Inc. (Bothell, WA) See Plans and Pricing
ISV-305 See Plans and Pricing Methods for the treatment of Kaposi's sarcoma or KSHV-induced lymphoma using immunomodulatory compounds, and uses of biomarkers Celgene Corporation (Summit, NJ) The United States of America, as Represented by the Secretary, Department of Health and Human Services (Washington, DC) See Plans and Pricing
ISV-305 See Plans and Pricing Use of inhibitors of Bruton'S tyrosine kinase (Btk) Pharmacyclics LLC (Sunnyvale, CA) See Plans and Pricing
ISV-305 See Plans and Pricing Method for differentially diagnosing ACTH-dependent cushing's syndrome Corcept Therapeutics, Inc. (Menlo Park, CA) See Plans and Pricing
ISV-305 See Plans and Pricing Tapered looped suture Covidien LP (Mansfield, MA) See Plans and Pricing
ISV-305 See Plans and Pricing Methods of treating cancer patients with farnesyltransferase inhibitors Kura Oncology, Inc. (La Jolla, CA) See Plans and Pricing
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for ISV-305

Drugname Country Document Number Estimated Expiration Related US Patent
ISV-305 Taiwan TW201718611 2035-08-26 See Plans and Pricing
ISV-305 World Intellectual Property Organization (WIPO) WO2017035357 2035-08-26 See Plans and Pricing
ISV-305 European Patent Office EP2556083 2030-04-05 See Plans and Pricing
ISV-305 World Intellectual Property Organization (WIPO) WO2011127048 2030-04-05 See Plans and Pricing
ISV-305 Australia AU2006269422 2025-07-07 See Plans and Pricing
ISV-305 Canada CA2614436 2025-07-07 See Plans and Pricing
ISV-305 European Patent Office EP1917020 2025-07-07 See Plans and Pricing
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Dow
Mallinckrodt
Medtronic
Johnson and Johnson
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.